Three months ended September 30, Nine months ended September 30, 2025 2024 2025 2024 Net sales $ 6,517 $ 6,294 $ 18,815 $ 18,565 Operating expenses Cost of sales 3,792 3,647 10,916 10,703 Selling, general and administrative expenses 820 1,062 3,032 3,322 Research, development and related expenses 297 269 870 803 Loss on business divestitures 161 — 164 — Total operating expenses 5,070 4,978 14,982 14,828 Operating income 1,447 1,316 3,833 3,737 Other expense (income), net 300 (405) 378 (323) Income from continuing operations before income taxes 1,147 1,721 3,455 4,060 Provision for income taxes 308 348 818 771 Income from continuing operations of consolidated group 839 1,373 2,637 3,289 Income from unconsolidated subsidiaries, net of taxes 2 3 51 7 Net income from continuing operations including noncontrolling interest 841 1,376 2,688 3,296 Less: net income attributable to noncontrolling interest 7 4 15 15 Net income from continuing operations attributable to 3M 834 1,372 2,673 3,281 Net income from discontinued operations, net of taxes — — — 164 Net income attributable to 3M $ 834 $ 1,372 $ 2,673 $ 3,445 Earnings per share attributable to 3M common shareholders: Weighted average 3M common shares outstanding — basic 534.1 550.6 538.4 553.1 Earnings per share from continuing operations — basic $ 1.56 $ 2.49 $ 4.97 $ 5.93 Earnings per share from discontinued operations — basic — — — 0.30 Earnings per share — basic $ 1.56 $ 2.49 $ 4.97 $ 6.23 Weighted average 3M common shares outstanding — diluted 538.1 552.7 542.1 554.5 Earnings per share from continuing operations — diluted $ 1.55 $ 2.48 $ 4.93 $ 5.92 Earnings per share from discontinued operations — diluted — — — 0.29 Earnings per share — diluted $ 1.55 $ 2.48 $ 4.93 $ 6.21 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 15 -- September 30, 2025 December 31, 2024 Assets Current assets Cash and cash equivalents $ 4,671 $ 5,600 Marketable securities – current 517 2,128 Accounts receivable – net 3,777 3,194 Inventories 3,893 3,698 Prepaids 514 493 Assets held for sale 44 — Other current assets 2,673 771 Total current assets 16,089 15,884 Property, plant and equipment – net 7,247 7,388 Operating lease right of use assets 537 565 Goodwill and intangible assets – net 7,543 7,491 Other assets 6,195 8,540 Total assets $ 37,611 $ 39,868 Liabilities and equity Current liabilities Short-term borrowings and current portion of long-term debt $ 749 $ 1,919 Accounts payable 2,735 2,660 Accrued payroll 668 712 Accrued income taxes 324 331 Operating lease liabilities – current 174 163 Liabilities held for sale 54 — Other current liabilities 4,029 5,471 Total current liabilities 8,733 11,256 Long-term debt 11,854 11,125 Other liabilities 12,349 13,593 Total liabilities 32,936 35,974 Total equity 4,675 3,894 Shares outstanding September 30, 2025: 531,225,048 December 31, 2024: 539,470,303 Total liabilities and equity $ 37,611 $ 39,868 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 15 -- Nine months ended September 30, 2025 2024 Net cash provided by (used in) operating activities $ 723 $ 1 Cash flows from investing activities: Purchases of property, plant and equipment (662) (890) Purchases and proceeds from sale or maturities of marketable securities and investments – net 2,346 (1,198) Proceeds from sale of businesses, net of cash sold 5 — Other investing activities 66 28 Net cash provided by (used in) investing activities 1,755 (2,060) Cash flows from financing activities: Change in debt – net (705) 5,509 Purchases of treasury stock (2,699) (1,096) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 1,219 68 Dividends paid to shareholders (1,175) (1,604) Cash transferred to Solventum related to separation, net — (616) Other financing activities (39) (83) Net cash provided by (used in) financing activities (3,399) 2,178 Effect of exchange rate changes on cash and cash equivalents 36 (2) Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale (885) 117 Less: net increase (decrease) in cash classified within assets held for sale 44 — Net increase (decrease) in cash and cash equivalents (929) 117 Cash and cash equivalents at beginning of year 5,600 5,933 Cash and cash equivalents at end of period $ 4,671 $ 6,050 The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet. 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 15 -- Three months ended September 30, 2025 Total company sales change by geographic area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 2.9 % 2.9 % 1.3 % 2.6 % Divestitures (0.1) — — (0.1) Translation 0.1 (0.1) 5.9 1.0 Total sales change 2.9 % 2.8 % 7.2 % 3.5 % Nine months ended September 30, 2025 Total company sales change by geographic area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 1.7 % 1.5 % (2.1) % 1.0 % Divestitures 0.4 0.1 0.2 0.3 Translation (0.6) (0.3) 2.7 — Total sales change 1.5 % 1.3 % 0.8 % 1.3 % Three months ended September 30, 2025 Sales change by reportable business segment Organic sales Divestitures Translation Total sales change Safety and Industrial 4.1 % — % 1.3 % 5.4 % Transportation and Electronics 1.8 (0.3) 0.9 2.4 Consumer 0.3 — 0.6 0.9 Nine months ended September 30, 2025 Sales change by reportable business segment Organic sales Divestitures Translation Total sales change Safety and Industrial 3.1 % — % 0.1 % 3.2 % Transportation and Electronics (1.2) (0.1) 0.1 (1.2) Consumer 0.3 — (0.2) 0.1 2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum. 3M Company and Subsidiaries SALES CHANGE2 (Unaudited) 4 -- 4 of 15 -- 3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Other”). Three months ended September 30, Nine months ended September 30, Net sales (millions) 2025 2024 2025 2024 Abrasives $ 344 $ 323 $ 999 $ 975 Automotive Aftermarket 293 313 874 923 Electrical Markets 373 328 1,047 952 Industrial Adhesives and Tapes 587 542 1,698 1,591 Industrial Specialties Division 297 292 879 873 Personal Safety 895 828 2,627 2,542 Roofing Granules 128 141 395 402 Total Safety and Industrial business segment 2,917 2,767 8,519 8,258 Advanced Materials 226 244 671 751 Automotive and Aerospace 484 469 1,433 1,456 Commercial Branding and Transportation 691 659 1,996 1,941 Electronics 790 767 2,211 2,238 Total Transportation and Electronics business segment 2,191 2,139 6,311 6,386 Consumer Safety and Well-Being 294 285 848 831 Home and Auto Care 304 291 909 898 Home Improvement 417 416 1,117 1,115 Packaging and Expression 297 307 832 858 Total Consumer business segment 1,312 1,299 3,706 3,702 Total reportable business segments 6,420 6,205 18,536 18,346 Corporate and Other 97 89 279 219 Total company $ 6,517 $ 6,294 $ 18,815 $ 18,565 Operating income (millions) Safety and Industrial $ 754 $ 650 $ 2,171 $ 1,919 Transportation and Electronics 482 436 1,296 1,345 Consumer 291 263 778 698 Total reportable business segments 1,527 1,349 4,245 3,962 Corporate and Other Corporate special items: Net costs for significant litigation 78 (25) (323) (96) Divestiture costs — — — (20) Loss on business divestitures (161) — (164) — Transformation costs (14) — (14) — Total corporate special items (97) (25) (501) (116) Other corporate (expense) income - net 17 (8) 89 (109) Total Corporate and Other (80) (33) (412) (225) Total company operating income 1,447 1,316 3,833 3,737 Other expense/(income), net 300 (405) 378 (323) Income from continuing operations before income taxes $ 1,147 $ 1,721 $ 3,455 $ 4,060 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) 5 -- 5 of 15 -- Corporate and Other Outside of 3M's reportable operating segments, 3M has Corporate and Other which is not a reportable business segment as it does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. Corporate and Other operating income (loss) includes: • Corporate special items include, for the periods presented: ◦ net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters, ◦ loss on business divestitures, ◦ divestiture costs (related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture) that were not eligible to be part of discontinued operations, and ◦ transformation program restructuring and related charges. • Other corporate (expense) income-net includes: ◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs that 3M may choose not to allocate directly to its business segments, ◦ commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the former Health Care business segment retained by 3M, ◦ transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Solventum Separation, ◦ operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with previous divestitures, and ◦ costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) 6 -- 6 of 15 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful: • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income (loss), segment operating income (loss) and operating income (loss) margin (and expansion) • Income from continuing operations before taxes • Provision for income taxes and effective tax rate • Net income from continuing operations • EPS from continuing operations Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 7 -- 7 of 15 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended September 30, 2024 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Operating income Operating income margin Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS Safety and Industrial GAAP amounts $ 650 23.5 % Adjustments for special items: Net costs for significant litigation 22 Adjusted amounts (non-GAAP measures)3 $ 672 24.3 % Transportation and Electronics GAAP amounts $ 2,139 $ 436 20.4 % Adjustments for special items: Manufactured PFAS products (226) 34 Adjusted amounts (non-GAAP measures)3 $ 1,913 $ 470 24.5 % Total company GAAP amounts $ 6,294 $ 1,316 20.9 % $ 1,721 $ 348 20.3 % $ 1,372 $ 2.48 Adjustments for special items: Net costs for significant litigation — 47 204 (75) 279 0.51 Manufactured PFAS products (226) 34 34 9 25 0.04 Solventum ownership - change in value — — (581) — (581) (1.05) Total special items (226) 81 (343) (66) (277) (0.50) Adjusted amounts (non-GAAP measures)3 $ 6,068 $ 1,397 23.0 % $ 1,378 $ 282 20.5 % $ 1,095 $ 1.98 Three months ended September 30, 2025 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Sales change Operating income Operating income margin Operating income margin expansion Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS EPS percent change Safety and Industrial GAAP amounts $ 754 25.9 % Adjustments for special items: Net costs for significant litigation 13 Adjusted amounts (non-GAAP measures)3 $ 767 26.3 % Transportation and Electronics GAAP amounts $ 2,191 2.4 % $ 482 22.0 % Adjustments for special items: Manufactured PFAS products (199) 2 Adjusted amounts (non-GAAP measures)3 $ 1,992 4.2 % $ 484 24.3 % Total company GAAP amounts $ 6,517 3.5 % $ 1,447 22.2 % 130 bps $ 1,147 $ 308 26.8 % $ 834 $ 1.55 (38) % Adjustments for special items: Net costs for significant litigation — (65) 56 (45) 101 0.19 Loss on business divestitures — 161 161 2 159 0.30 Manufactured PFAS products (199) 2 2 1 1 — Solventum ownership - change in value — — 94 23 71 0.13 Transformation costs — 14 14 3 11 0.02 Total special items (199) 112 327 (16) 343 0.64 Adjusted amounts (non-GAAP measures)3 $ 6,318 4.1 % $ 1,559 24.7 % 170 bps $ 1,474 $ 292 19.9 % $ 1,177 $ 2.19 10 % 3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 8 -- 8 of 15 -- Nine months ended September 30, 2024 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Operating income Operating income margin Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS Safety and Industrial GAAP amounts $ 1,919 23.2 % Adjustments for special items: Net costs for significant litigation 40 Adjusted amounts (non-GAAP measures)3 $ 1,959 23.7 % Transportation and Electronics GAAP amounts $ 6,386 $ 1,345 21.1 % Adjustments for special items: Manufactured PFAS products (743) 30 Adjusted amounts (non-GAAP measures)3 $ 5,643 $ 1,375 24.4 % Total Company GAAP amounts $ 18,565 $ 3,737 20.1 % $ 4,060 $ 771 19.0 % $ 3,281 $ 5.92 Adjustments for special items: Net costs for significant litigation — 136 699 (69) 768 1.39 Divestiture costs — 20 20 (111) 131 0.24 Manufactured PFAS products (743) 30 30 7 23 0.04 Pension risk transfer charge — — 795 188 607 1.09 Solventum ownership - change in value — — (1,694) — (1,694) (3.06) Total special items (743) 186 (150) 15 (165) (0.30) Adjusted amounts (non-GAAP measures)3 $ 17,822 $ 3,923 22.0 % $ 3,910 $ 786 20.1 % $ 3,116 $ 5.62 Nine months ended September 30, 2025 Amounts from continuing operations (Dollars in millions, except per share amounts) Net sales Sales change Operating income Operating income margin Operating income margin expansion Income before taxes Provision for income taxes Effective tax rate Net income attributable to 3M EPS EPS percent change Safety and Industrial GAAP amounts $ 2,171 25.5 % Adjustments for special items: Net costs for significant litigation 33 Adjusted amounts (non-GAAP measures)3 $ 2,204 25.9 % Transportation and Electronics GAAP amounts $ 6,311 (1.2) % $ 1,296 20.5 % Adjustments for special items: Manufactured PFAS products (559) 57 Adjusted amounts (non-GAAP measures)3 $ 5,752 1.9 % $ 1,353 23.5 % Total Company GAAP amounts $ 18,815 1.3 % $ 3,833 20.4 % 30 bps $ 3,455 $ 818 23.7 % $ 2,673 $ 4.93 (17) % Adjustments for special items: Net costs for significant litigation — 356 751 (1) 752 1.39 Loss on business divestitures — 164 164 3 161 0.30 Manufactured PFAS products (559) 57 57 14 43 0.08 Solventum ownership - change in value — — (242) 23 (265) (0.49) Transformation costs — 14 14 3 11 0.02 Total special items (559) 591 744 42 702 1.30 Adjusted amounts (non-GAAP measures)3 $ 18,256 2.4 % $ 4,424 24.2 % 220 bps $ 4,199 $ 860 20.5 % $ 3,375 $ 6.23 11 % 2025 forecast 2025 adjusted operating income margin expansion (non-GAAP measure)3,4 180 bps to 200 bps 2025 adjusted earnings per share from continuing operations (non-GAAP measure)3,4 $7.95 to $8.05 43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 9 -- 9 of 15 -- Three months ended September 30, 2025 Sales change2 Organic sales Acquisitions Divestitures Translation Total sales change Total company 2.6 % — % (0.1) % 1.0 % 3.5 % Remove manufactured PFAS products special item impact 0.6 — — — 0.6 Adjusted total company (non-GAAP measures)3 3.2 % — % (0.1) % 1.0 % 4.1 % Transportation and Electronics 1.8 % — % (0.3) % 0.9 % 2.4 % Remove manufactured PFAS products special item impact 1.8 — — — 1.8 Adjusted Transportation and Electronics (non-GAAP measures)3 3.6 % — % (0.3) % 0.9 % 4.2 % By Geographic Area Americas 2.9 % — % (0.1) % 0.1 % 2.9 % Remove manufactured PFAS products special item impact 0.2 — (0.1) — 0.1 Adjusted Americas (non-GAAP measures)3 3.1 % — % (0.2) % 0.1 % 3.0 % Asia Pacific 2.9 % — % — % (0.1) % 2.8 % Remove manufactured PFAS products special item impact 1.3 — — 0.1 1.4 Adjusted Asia Pacific (non-GAAP measures)3 4.2 % — % — % — % 4.2 % Europe, Middle East & Africa 1.3 % — % — % 5.9 % 7.2 % Remove manufactured PFAS products special item impact 0.9 — — 0.1 1.0 Adjusted Europe, Middle East & Africa (non-GAAP measures)3 2.2 % — % — % 6.0 % 8.2 % By Particular Country United States 3.6 % — % (0.2) % — % 3.4 % Remove manufactured PFAS products special item impact — — 0.1 — 0.1 Adjusted United States (non-GAAP measures)3 3.6 % — % (0.1) % — % 3.5 % China 9.4 % — % — % 0.1 % 9.5 % Remove manufactured PFAS products special item impact (1.3) — — — (1.3) Adjusted China (non-GAAP measures)3 8.1 % — % — % 0.1 % 8.2 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 10 -- 10 of 15 -- Nine months ended September 30, 2025 Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change Total Company 1.0 % — % 0.3 % — % 1.3 % Remove manufactured PFAS products special item impact 1.1 — — — 1.1 Adjusted total Company (non-GAAP measures)3 2.1 % — % 0.3 % — % 2.4 % Transportation and Electronics (1.2) % — % (0.1) % 0.1 % (1.2) % Remove manufactured PFAS products special item impact 3.1 — — — 3.1 Adjusted Transportation and Electronics (non-GAAP measures)3 1.9 % — % (0.1) % 0.1 % 1.9 % By Geographic Area Americas 1.7 % — % 0.4 % (0.6) % 1.5 % Remove manufactured PFAS products special item impact 0.2 — — 0.1 0.3 Adjusted Americas (non-GAAP measures)3 1.9 % — % 0.4 % (0.5) % 1.8 % Asia Pacific 1.5 % — % 0.1 % (0.3) % 1.3 % Remove manufactured PFAS products special item impact 2.1 — — — 2.1 Adjusted Asia Pacific (non-GAAP measures)3 3.6 % — % 0.1 % (0.3) % 3.4 % Europe, Middle East & Africa (2.1) % — % 0.2 % 2.7 % 0.8 % Remove manufactured PFAS products special item impact 2.2 — — 0.1 2.3 Adjusted Europe, Middle East & Africa (non-GAAP measures)3 0.1 % — % 0.2 % 2.8 % 3.1 % By Particular Country United States 1.6 % — % 0.6 % — % 2.2 % Remove manufactured PFAS products special item impact 0.2 — — — 0.2 Adjusted United States (non-GAAP measures)3 1.8 % — % 0.6 % — % 2.4 % China 6.3 % — % 0.1 % (0.2) % 6.2 % Remove manufactured PFAS products special item impact 0.1 — 0.1 (0.1) 0.1 Adjusted China (non-GAAP measures)3 6.4 % — % 0.2 % (0.3) % 6.3 % 2025 forecast Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change Total Company4 >2% — % ~0.5% — % >2.5% Remove manufactured PFAS products impact4 — — — — — Adjusted total company (non-GAAP measures)3,4 >2% — % ~0.5% — % >2.5% Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended September 30, Nine months ended September 30, Major GAAP cash flow categories (dollars in millions) 2025 2024 2025 2024 Net cash provided by (used in) operating activities $ 1,756 $ (1,787) $ 723 $ 1 Net cash provided by (used in) investing activities 465 (1,204) 1,755 (2,060) Net cash provided by (used in) financing activities (1,208) (1,085) (3,399) 2,178 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 11 -- 11 of 15 -- Three months ended September 30, Nine months ended September 30, Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2025 2024 2025 2024 Net cash provided by (used in) operating activities $ 1,756 $ (1,787) $ 723 $ 1 Adjustments for special items: Net costs/(recoveries) for significant litigation after-tax payment impacts (200) 3,550 2,803 4,023 Divestiture costs after-tax payment impacts 26 53 85 328 Divestiture-related restructuring after-tax payment impacts — — — 2 TCJA transition tax payment — — 211 193 Manufactured PFAS products after-tax payment impacts (60) (38) (92) (166) Total adjustments for special items (234) 3,565 3,007 4,380 Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5 $ 1,522 $ 1,778 $ 3,730 $ 4,381 Purchases of property, plant and equipment (PPE) (218) (246) (662) (890) Manufactured PFAS products impact - removing related purchases of PPE 6 14 15 53 Adjusted purchases of PPE (non-GAAP measure)5 $ (212) $ (232) $ (647) $ (837) Adjusted free cash flow (non-GAAP measure)5 $ 1,310 $ 1,546 $ 3,083 $ 3,544 Net income attributable to 3M $ 834 $ 1,372 $ 2,673 $ 3,445 Adjustments for special items, net of tax: Net costs for significant litigation 101 279 752 768 Manufactured PFAS products impact 1 25 43 23 Loss on business divestitures 159 — 161 — Divestiture costs — — — 341 Solventum ownership - change in value 71 (581) (265) (1,694) Pension risk transfer charge — — — 607 Transformation costs 11 — 11 — Total adjustments for special items, net of tax 343 (277) 702 45 Net income attributable to 3M adjusted for special items (used for adjusted free cash flow conversion calculation) $ 1,177 $ 1,095 $ 3,375 $ 3,490 Adjusted free cash flow conversion (non-GAAP measure)5 111 % 141 % 91 % 102 % 53M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 and 2025 settlement/proposed settlement agreements relative to Combat Arms Earplugs and relative to public water suppliers and the state of New Jersey regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items (used for adjusted free cash flow conversion calculation). 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 12 -- 12 of 15 -- (Dollars in billions) 2025 forecast Net cash provided by (used in) operating activities $5.2 to $5.4 Adjustments for special items4 — Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4,5 $5.2 to $5.4 Purchase of property, plant and equipment (PPE) (~$0.9) Manufactured PFAS products impact — removing related purchases of PPE — Adjusted purchases of PPE (non-GAAP measure)5 (~$0.9) Adjusted free cash flow (non-GAAP measure)4,5 $4.3 to $4.5 Net income attributable to 3M $4.3 to $4.4 Adjustments for special items4 — Adjusted net income attributable to 3M (non-GAAP measure)3,4 $4.3 to $4.4 Adjusted free cash flow conversion (non-GAAP measure)4,5 >100% 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 13 -- 13 of 15 -- Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Other. In the third quarter of 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $(32) million and $3.7 billion, respectively, related to net costs for significant litigation. In the first nine months of 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $3.3 billion and $4.5 billion, respectively, related to net costs for significant litigation. Loss on business divestitures: • In the third quarter of 2025, 3M reflected a write-down for a business classified as held for sale. In second quarter of 2025, 3M completed a divestiture for immaterial proceeds slightly below the business's book value. Divestiture costs: • These include certain limited costs that were not eligible to be included within discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of updating 3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs that included within discontinued operations, including interest expense on debt issued by Solventum for the period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity structuring associated with the separation of Solventum. In the third quarter and first nine months of 2024, 3M made pre- tax cash payments of $25 million and $217 million, respectively, associated with divestiture costs. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the first nine months of 2024, 3M made pre-tax cash payments of $2 million associated with divestiture-related restructuring actions. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA): • In the first nine months of 2025 and 2024, 3M made payments of $211 million and $193 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. Manufactured PFAS products: • These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non- service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 14 -- 14 of 15 -- Pension risk transfer charge: • In the second quarter of 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income), net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance company Solventum ownership - change in value: • This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in other expense (income), net. Transformation costs: • These represent net costs associated with 3M's transformation program, intended as a structural redesign of longer-term manufacturing, distribution, and business process services and locations. Accordingly, 3M does not consider the nature or effect of this program to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, and day-to-day business strategy. Net costs include restructuring and other related items such as site closure, sale, moving and set-up, accelerated depreciation, and program management. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 15 -- 15 of 15 --